Cargando…
Risk factors and clinical outcomes associated with acquired hypofibrinogenemia in patients administered hemocoagulase batroxobin for hemoptysis
BACKGROUND: Hemocoagulase batroxobin is used to prevent hemostasis or bleeding in surgical and trauma patients; however, the role of batroxobin in patients with hemoptysis is not well understood. We evaluated the risk factors and prognosis of acquired hypofibrinogenemia in hemoptysis patients treate...
Autores principales: | Lee, Jae-Kyeong, Yoon, Chang-Seok, Na, Young-Ok, Park, Hwa Kyung, Oh, Hyung-Joo, Kho, Bo-Gun, Park, Ha-Young, Kim, Tae-Ok, Shin, Hong-Joon, Kwon, Yong-Soo, Kim, Yu-Il, Lim, Sung-Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922611/ https://www.ncbi.nlm.nih.gov/pubmed/36794140 http://dx.doi.org/10.21037/jtd-22-717 |
Ejemplares similares
-
Paradoxical pulmonary hemorrhage associated with hemocoagulase batroxobin in a patient with hemoptysis: A CARE-compliant case report
por: Kim, Tae-Ok, et al.
Publicado: (2021) -
Hypofibrinogenemia Caused by Hemocoagulase After Colon Polyps Excision
por: Zhou, Hai-Bo
Publicado: (2017) -
Life-threatening Mycobacterium intracellulare pleuritis in an immunocompetent host: Case reports
por: Kho, Bo-Gun, et al.
Publicado: (2021) -
Usefulness of Mycobacterium tuberculosis-polymerase chain reaction with bronchial washing samples in predicting discontinuation of airborne infection isolation in patients hospitalized with suspected pulmonary tuberculosis
por: Kim, Tae-Ok, et al.
Publicado: (2022) -
Acquired hypofibrinogenemia: current perspectives
por: Besser, Martin W, et al.
Publicado: (2016)